8th Sep 2020 15:45
Phimedix PLC - Cash shell - Narrows pretax loss in year ended March 31 to GBP204,000 from GBP7.0 million. Phimedix disposed of main operating subsidiary Masterpiece back in March and is now a cash shell, but is in early stage talks to find a reverse acquisition. Notes London Stock Exchange is expected to suspended trading of Phimedix shares on September 14 and could cancel listing six months later should no acquisition be made. Stock was down 78% on Tuesday afternoon in London.
Current stock price: 0.99 pence
Year-to-date change: up 66%
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
PHM.L